Jonathan Poole
2019 - Evelo Biosciences
In 2019, Jonathan Poole earned a total compensation of $1.4M as Former Chief Financial Officer at Evelo Biosciences, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $123,200 |
|---|---|
| Option Awards | $930,000 |
| Salary | $385,000 |
| Other | $6,000 |
| Total | $1,444,200 |
Poole received $930K in option awards, accounting for 64% of the total pay in 2019.
Poole also received $123.2K in non-equity incentive plan, $385K in salary and $6K in other compensation.
Rankings
In 2019, Jonathan Poole's compensation ranked 7,489th out of 13,971 executives tracked by ExecPay. In other words, Poole earned more than 46.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,489 out of 13,971 | 46th |
Division Manufacturing | 2,905 out of 5,701 | 49th |
Major group Chemicals And Allied Products | 1,093 out of 2,200 | 50th |
Industry group Drugs | 930 out of 1,886 | 51st |
Industry Pharmaceutical Preparations | 687 out of 1,398 | 51st |
Source: SEC filing on April 27, 2020.
Poole's colleagues
We found two more compensation records of executives who worked with Jonathan Poole at Evelo Biosciences in 2019.